Skip to main content
Top
Published in: Molecular Imaging and Biology 2/2009

01-03-2009 | Research Article

Increasing Uptake Time in FDG-PET: Standardized Uptake Values in Normal Tissues at 1 versus 3 h

Authors: Bennett B. Chin, Edward D. Green, Timothy G. Turkington, Thomas C. Hawk, R. Edward Coleman

Published in: Molecular Imaging and Biology | Issue 2/2009

Login to get access

Abstract

Objective

Positron emission tomography (PET) imaging at more than 1 h after 2-deoxy-2-[18F]fluoro-d-glucose (FDG) administration may result in less blood pool activity and possibly decreased normal FDG uptake in tissues such as liver. Lower normal background activity could be an important component of improved image contrast on delayed imaging. Increasing FDG uptake in normal organs, however, may mitigate the beneficial effects of blood pool clearance. The purpose of this study is to determine the normal tissue and blood pool FDG uptake at 1 and 3 h after injection.

Subjects and methods

Ninety-nine patients with known or suspected malignancy referred for FDG-PET–computed tomography (CT) were retrospectively evaluated. PET imaging was performed at either 1 h (60 ± 15 min; n = 50) or at 3 h (180 ± 15 min; n = 49) after FDG administration. Normal tissue FDG uptake without involvement by malignancy or influenced by artifact (misregistration, “brown fat,” focal muscle uptake, focal atherosclerotic disease) was confirmed by inspection of both the PET and CT scans. Aortic blood pool, adipose tissue, bone marrow, cerebellum, liver, lungs, muscle, and spleen were quantitatively evaluated by CT-guided region of interest analysis in three contiguous slices. Mean standardized uptake values (SUVs) were analyzed using one-way analysis of variance.

Results

Mean SUVs on the 3- versus 1-h images were significantly lower for aortic blood pool 13% (p < 0.0001) and adipose tissue 20% (p < 0.008). FDG uptake showed significant increases at 3 h compared to 1-h imaging in the cerebellum 40% (p < 0.0001), bone marrow 25% (p = 0.003), muscle 21% (p = 0.0004), and spleen 13% (p = 0.01). The liver and lung showed no significant differences (1%, p = 0.85; −2%, p = 0.62, respectively).

Conclusions

On FDG imaging at 3 h compared to 1 h, significant changes were apparent, but the magnitude of changes was modest overall. Three-hour delayed imaging demonstrated significantly lower aortic blood pool and adipose tissue activity and significantly higher cerebellum, muscle, spleen, and bone marrow activity. Hepatic and lung activities were not significantly different. These results suggest that previously reported improvements in tumor image contrast with delayed imaging may be primarily due to cumulative FDG uptake within the tumor rather than reduction in normal background activity.
Literature
1.
go back to reference Wang Y, Chiu E, Rosenberg J et al (2007) Standardized uptake value atlas: characterization of physiological 2-deoxy-2-[18F]fluoro-d-glucose uptake in normal tissues. Mol Imaging Biol 9:83–90PubMedCrossRef Wang Y, Chiu E, Rosenberg J et al (2007) Standardized uptake value atlas: characterization of physiological 2-deoxy-2-[18F]fluoro-d-glucose uptake in normal tissues. Mol Imaging Biol 9:83–90PubMedCrossRef
2.
go back to reference Spence AM, Muzi M, Mankoff DA et al (2004) 18F-FDG-PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. J Nucl Med 45:1653–1659PubMed Spence AM, Muzi M, Mankoff DA et al (2004) 18F-FDG-PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. J Nucl Med 45:1653–1659PubMed
3.
go back to reference Mavi A, Urhan M, Yu JQ et al (2006) Dual time point 18F-FDG-PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med 47:1440–1446PubMed Mavi A, Urhan M, Yu JQ et al (2006) Dual time point 18F-FDG-PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med 47:1440–1446PubMed
4.
go back to reference Xiu Y, Bhutani C, Dhurairaj T et al (2007) Dual-time point FDG-PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med 32:101–105PubMedCrossRef Xiu Y, Bhutani C, Dhurairaj T et al (2007) Dual-time point FDG-PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med 32:101–105PubMedCrossRef
5.
go back to reference Nakamoto Y, Higashi T, Sakahara H et al (2000) Delayed (18)F-fluoro-2-deoxy-d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 89:2547–2554PubMedCrossRef Nakamoto Y, Higashi T, Sakahara H et al (2000) Delayed (18)F-fluoro-2-deoxy-d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 89:2547–2554PubMedCrossRef
6.
go back to reference Higashi T, Saga T, Nakamoto Y et al (2002) Relationship between retention index in dual-phase (18)F-FDG-PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43:173–180PubMed Higashi T, Saga T, Nakamoto Y et al (2002) Relationship between retention index in dual-phase (18)F-FDG-PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43:173–180PubMed
7.
go back to reference Nishiyama Y, Yamamoto Y, Monden T et al (2005) Evaluation of delayed additional FDG-PET imaging in patients with pancreatic tumour. Nucl Med Commun 26:895–901PubMedCrossRef Nishiyama Y, Yamamoto Y, Monden T et al (2005) Evaluation of delayed additional FDG-PET imaging in patients with pancreatic tumour. Nucl Med Commun 26:895–901PubMedCrossRef
8.
go back to reference Nishiyama Y, Yamamoto Y, Fukunaga K et al (2006) Dual-time-point 18F-FDG-PET for the evaluation of gallbladder carcinoma. J Nucl Med 47:633–638PubMed Nishiyama Y, Yamamoto Y, Fukunaga K et al (2006) Dual-time-point 18F-FDG-PET for the evaluation of gallbladder carcinoma. J Nucl Med 47:633–638PubMed
9.
go back to reference Lin WY, Tsai SC, Hung GU (2005) Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun 26:315–321PubMedCrossRef Lin WY, Tsai SC, Hung GU (2005) Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun 26:315–321PubMedCrossRef
10.
go back to reference Lai CH, Huang KG, See LC et al (2003) Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-d-glucose positron emission tomography. Cancer 100:544–552CrossRef Lai CH, Huang KG, See LC et al (2003) Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-d-glucose positron emission tomography. Cancer 100:544–552CrossRef
11.
go back to reference Ma SY, See LC, Lai CH et al (2003) Delayed (18)F-FDG-PET for detection of para-aortic lymph node metastases in cervical cancer patients. J Nucl Med 44:1775–1783PubMed Ma SY, See LC, Lai CH et al (2003) Delayed (18)F-FDG-PET for detection of para-aortic lymph node metastases in cervical cancer patients. J Nucl Med 44:1775–1783PubMed
12.
go back to reference Dobert N, Hamscho N, Menzel C et al (2004) Limitations of dual time point FDG-PET imaging in the evaluation of focal abdominal lesions. Nuklearmedizin 43:143–149PubMed Dobert N, Hamscho N, Menzel C et al (2004) Limitations of dual time point FDG-PET imaging in the evaluation of focal abdominal lesions. Nuklearmedizin 43:143–149PubMed
13.
go back to reference Demura Y, Tsuchida T, Ishizaki T et al (2003) 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 43:540–548 Demura Y, Tsuchida T, Ishizaki T et al (2003) 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 43:540–548
14.
go back to reference Hamada K, Tomita Y, Ueda T et al (2006) Evaluation of delayed 18F-FDG-PET in differential diagnosis for malignant soft-tissue tumors. Ann Nucl Med 20:671–675PubMedCrossRef Hamada K, Tomita Y, Ueda T et al (2006) Evaluation of delayed 18F-FDG-PET in differential diagnosis for malignant soft-tissue tumors. Ann Nucl Med 20:671–675PubMedCrossRef
15.
go back to reference Kubota K, Itoh M, Ozaki K et al (2001) Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 28:696–703PubMedCrossRef Kubota K, Itoh M, Ozaki K et al (2001) Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 28:696–703PubMedCrossRef
16.
go back to reference Zhuang H, Pourdehnad M, Lambright ES et al (2001) Dual time point 18F-FDG-PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42:1412–1417PubMed Zhuang H, Pourdehnad M, Lambright ES et al (2001) Dual time point 18F-FDG-PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42:1412–1417PubMed
17.
go back to reference Yen TC, Chang YC, Chan SC et al (2005) Are dual-phase 18F-FDG-PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging 32:541–548PubMedCrossRef Yen TC, Chang YC, Chan SC et al (2005) Are dual-phase 18F-FDG-PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging 32:541–548PubMedCrossRef
18.
go back to reference Minn H, Zasadny KR, Quint LE et al (1995) Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-d-glucose uptake at PET. Radiology 196:167–173PubMed Minn H, Zasadny KR, Quint LE et al (1995) Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-d-glucose uptake at PET. Radiology 196:167–173PubMed
19.
go back to reference Weber WA, Ziegler SI, Thodtmann R et al (1999) Reproducibility of metabolic measurements in malignant tumors using FDG-PET. J Nucl Med 40:1771–1777PubMed Weber WA, Ziegler SI, Thodtmann R et al (1999) Reproducibility of metabolic measurements in malignant tumors using FDG-PET. J Nucl Med 40:1771–1777PubMed
Metadata
Title
Increasing Uptake Time in FDG-PET: Standardized Uptake Values in Normal Tissues at 1 versus 3 h
Authors
Bennett B. Chin
Edward D. Green
Timothy G. Turkington
Thomas C. Hawk
R. Edward Coleman
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Molecular Imaging and Biology / Issue 2/2009
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-008-0177-9

Other articles of this Issue 2/2009

Molecular Imaging and Biology 2/2009 Go to the issue